In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL
- 1 September 1998
- Vol. 52 (3) , 360-365
- https://doi.org/10.1016/s0090-4295(98)00245-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Free-To-Total Prostate Specific Antigen Ratio Improves the Specificity of Prostate Specific Antigen in Screening for Prostate Cancer in the General PopulationJournal of Urology, 1997
- Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, 1995
- Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new eraUrology, 1995
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate CancerJournal of Urology, 1993
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992
- The Use of Prostate Specific Antigen Density to Enhance the Predictive Value of Intermediate Levels of Serum Prostate Specific AntigenJournal of Urology, 1992
- Tissue-specific and hormonal regulations of human prostate-specific glandular kallikreinBiochemistry, 1992
- cDNA coding for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genesBiochemical and Biophysical Research Communications, 1989
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987